Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach-Reference-Cited by-同舟云学术

Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach

Published:2019-05 Issue: Volume:18 Page:36-46
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Foos Volker,Wang Ke,McEwan Phil,Zhang Yanlei,Xin Ping,Jiang Xiaohua,Qu Shuli,Xiong Tengbin,De Moor Raf,Ramos Mafalda,Lamotte Mark,Ji Linong

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference71 articles.

1. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030;Wild;Diabetes Care,2004

2. Prevalence of diabetes among men and women in China;Yang;N Engl J Med,2010

3. IDF Diabetes Atlas—7th ed: China country report. International Diabetes Federation Diabetes. http://reports.instantatlas.com/report/view/846e76122b5f476fa6ef09471965aedd/CHN. Accessed December 13, 2016.

4. Standards of care for type 2 diabetes in China;Weng;Diabetes Metab Res Rev,2016

5. A systematic review of the direct economic burden of type 2 diabetes in China;Hu;Diabetes Ther,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burden of Illness of Type 2 Diabetes Mellitus in the Kingdom of Saudi Arabia: A Five-Year Longitudinal Study;Advances in Therapy;2024-01-19

2. Potential health and economic impact associated with achieving risk factor control in Chinese adults with diabetes: a microsimulation modelling study;The Lancet Regional Health - Western Pacific;2023-04

3. Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China;Cost Effectiveness and Resource Allocation;2021-08-04

4. Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial;American Heart Journal;2021-08

5. Cost–effectiveness analysis of empagliflozin compared with glimepiride in patients with Type 2 diabetes in China;Journal of Comparative Effectiveness Research;2021-04